Optimizing antibiotic therapy of group IV community-acquired pneumonia patients
Journal Title: Медичні перспективи - Year 2014, Vol 19, Issue 2
Abstract
The aim of the study was to evaluate the clinical and economical effectiveness of differentiated antibacterial therapy of group IV patients with community-acquired pneumonia (CAP). Materials and methods. 42 patients, admitted to the hospital with severe CAP without risk factors for P. aeruginosa infection were randomized in three groups in 1:1:1 ratio. All patients received sequential antibacterial therapy with i.v. amoxicillin/clavulanate or ceftriaxone, or ertapenem in combination with azithromycin switched to oral amoxicillin/clavulanate, cefuroxime axetil in combination with oral azithromycin or levofloxacin, respectively, after initial improvement in 3–4 days. A comparative effectiveness analysis was performed based on clinical, laboratory and economic data. Results. Treatment outcomes in all subgroups of patients were similar: in 1st subgroup the cure rate was (28,6 12,1) %, improvement – in (49,4 13,2) % of patients; in 2nd and 3rd subgroups the cure/improvement rates were (35,7 12,8) and (42,9 13,2) %, respectively (р 0,05). Conclusion. Antibacterial therapy, always empiric and differentiated depending on severity of disease, con¬comitant conditions and previous use of antibiotics within 3 months of the onset of the disease, is a milestone of treatmet of CAP patients. A sequential antibiotic therapy with either aminopenicillin (amoxicillin/clavulanate) of 3rd generation cephalosporin (ceftriaxone/cefuroxime axetil) in combination with macrolide (azithromycin) or carbapenem (ertapenem, followed by levofloxacin) is recommended in hospitalized clinical group IV CAP patients without risk factors for P. aeruginosa infection. In current group of patients pharmacoeconomic analysis confirmed the expediency of administration a sequential antibiotic therapy with parenteral amoxicillin/clavulanat or ceftriaxone in combination with azithromycin, followed by oral amoxicillin/clavulanat or cefuroxime axetil in combination with azithromycin upon stabilization of patient’s condition.
Authors and Affiliations
Ya. Dziublyk
Keywords
Related Articles
- EP ID EP94308
- DOI -
- Views 131
- Downloads 0
Optimizing antibiotic therapy of group IV community-acquired pneumonia patients
The aim of the study was to evaluate the clinical and economical effectiveness of differentiated antibacterial therapy of group IV patients with community-acquired pneumonia (CAP). Materials and methods. 42 patients, adm...
Active prevention of postpartum endometritis in pregnant women with anaerobic dysbiosis and planned cesarian section
In the structure of inflammatory diseases postpartum endometritis (PE) retains its leading position. The likelihood of postpartum endometritis development after cesarean section increases by 5-10 times compared with spon...
Сполучена дія хімічних та фізичних чинників на репродуктивну систему щурів в умовах холодового стресу
Приведены результаты экспериментальных исследований по изучению особенностей гонадотоксического действия НБ, МТБЭ и ЭМИ в условиях холодового стресса, а также в условиях температурного комфорта. Исследования проводились...
Нейротропное действие соевого лецитина в процессе формирования когнитивной функции у белых крыс
В експериментах на білих щурах вивчалася нейротропна дія соєвого лецитину, відомого як джерело поліненасичених жирних кислот, на фоні нейротоксичного впливу чотирьоххлористого вуглецю. Курсове введення CCl4 виявило суттє...
Гігієнічна оцінка азбестовмісного пилу в повітрі робочої зони теплових електростанцій
На теплоэлектростанциях (ТЭС) в значительных количествах использовался асбест и искусственные минеральные волокна в виде теплоизоляции трубопроводов, герметизирующих прокладок, изоляторов и др. Но до настоящего времени с...